Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study
Year: 1999
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Osteoporosis International
DOI: 10.1007/pl00004171
Authors: H. A. P. Pols, D. Felsenberg, D. A. Hanley, J. Štepán, M. Muñoz-Torres, T. J. Wilkin, G. Qin-sheng, A. M. Galich, K. Vandormael, A. J. Yates, B. Stych, for the Fosamax® International Trial Study Group
Institutions: Erasmus MC, Erasmus University Rotterdam, Freie Universität Berlin, University of Calgary, Charles University, Plymouth Hospital, University Hospitals Plymouth NHS Trust, Peking Union Medical College Hospital, Hospital Italiano de Buenos Aires, Merck & Co., Inc., Rahway, NJ, USA (United States)
Language: English
Subfield: Orthopedics and Sports Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2034238658
